Mester J - Search Results

1

Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.

Apostolova I, Wiemker R, Paulus T, Kabus S, Dreilich T, van den Hoff J, Plotkin M, Mester J, Brenner W, Buchert R, Klutmann S. Apostolova I, et al. Among authors: mester j. Eur Radiol. 2010 Aug;20(8):1868-77. doi: 10.1007/s00330-010-1747-1. Epub 2010 Mar 20. Eur Radiol. 2010. PMID: 20306084

2

Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.

Bohuslavizki KH, Klutmann S, Brenner W, Mester J, Henze E, Clausen M. Bohuslavizki KH, et al. Among authors: mester j. J Clin Oncol. 1998 Nov;16(11):3542-9. doi: 10.1200/JCO.1998.16.11.3542. J Clin Oncol. 1998. PMID: 9817273 Clinical Trial.

3

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Bleckmann C, Brenner W, Lassmann S, Mester J, Henze E, Clausen M. Bohuslavizki KH, et al. Among authors: mester j. Strahlenther Onkol. 1999 Feb;175(2):57-61. doi: 10.1007/BF02753843. Strahlenther Onkol. 1999. PMID: 10065139 Clinical Trial.

4

[Onco-PET: lesion detection by monitor versus standardized film documentation].

Bleckmann C, Buchert R, Schulte U, Lorenzen J, Bohuslavizki KH, Mester J, Clausen M. Bleckmann C, et al. Among authors: mester j. Nuklearmedizin. 1999;38(2):56-60. Nuklearmedizin. 1999. PMID: 10100232 German.

5

Quantitative salivary gland scintigraphy.

Klutmann S, Bohuslavizki KH, Kröger S, Bleckmann C, Brenner W, Mester J, Clausen M. Klutmann S, et al. Among authors: mester j. J Nucl Med Technol. 1999 Mar;27(1):20-6. J Nucl Med Technol. 1999. PMID: 10322570 Free article.

6

Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma.

Klutmann S, Bohuslavizki KH, Tietje N, Kröger S, Behnke A, Brenner W, Mester J, Henze E, Clausen M. Klutmann S, et al. Among authors: mester j. J Nucl Med. 1999 Aug;40(8):1246-51. J Nucl Med. 1999. PMID: 10450673 Free article.

7

[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].

Bohuslavizki KH, Klutmann S, Sonnemann U, Thoms J, Kröger S, Werner JA, Mester J, Clausen M. Bohuslavizki KH, et al. Among authors: mester j. Laryngorhinootologie. 1999 Aug;78(8):445-9. doi: 10.1055/s-2007-996906. Laryngorhinootologie. 1999. PMID: 10488465 German.

8

Quality assurance in PET: evaluation of the clinical relevance of detector defects.

Buchert R, Bohuslavizki KH, Mester J, Clausen M. Buchert R, et al. Among authors: mester j. J Nucl Med. 1999 Oct;40(10):1657-65. J Nucl Med. 1999. PMID: 10520706 Free article.

9

Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Brenner W, Kröger S, Buchert R, Bleckmann C, Mester J, Henze E, Clausen M. Bohuslavizki KH, et al. Among authors: mester j. Strahlenther Onkol. 1999 Nov;175 Suppl 4:6-12. Strahlenther Onkol. 1999. PMID: 10584133 Clinical Trial.

10

Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

Bleckmann C, Dose J, Bohuslavizki KH, Buchert R, Klutmann S, Mester J, Jänicke F, Clausen M. Bleckmann C, et al. Among authors: mester j. J Nucl Med. 1999 Dec;40(12):2021-4. J Nucl Med. 1999. PMID: 10616880 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters